KaliVir Immunotherapeutics
Greg Delgoffe is on the Board of Advisors at KaliVir Immunotherapeutics. Greg is also the Associate Professor at University of Pittsburgh School of Medicine.
This person is not in the org chart
This person is not in any offices
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells